HI-Bio
Hannah Lock has a diverse work experience. In 2018, they worked as a Private Tutor. From 2019 to 2020, they were a UCEAP Global Intern, where they focused on promoting studying abroad opportunities for STEM majors. Starting in 2020, they became an Undergraduate Research Assistant at the Department of Molecular Cellular and Developmental Biology at UC Santa Barbara, where they examined the function of the destruction complex organelle and its relation to the Wnt signaling pathway. Hannah was also a Chemistry/Biology CLAS Tutor at UC Santa Barbara during this time. In 2022, Hannah joined HI-Bio as a Research Associate in Immunology. Additionally, they participated in the UCLA Systems Biology Conference in the same year.
Hannah Lock pursued their Bachelor of Science degree in Biochemistry from UC Santa Barbara from 2018 to 2022. Additionally, in 2019, they attended the University of Sussex International Summer School, where they studied Introductory Physics 1-2.
HI-Bio
HI-Bio was established on the premise that treatments for immune-mediated illnesses have the potential to provide patients with better outcomes. Many IMDs are caused by immune system cells, such as mast cells, neutrophils, plasma cells, and more, which are dysfunctional. These cells are in charge of crucial processes and functions. With the useof medicines, HI-efforts Bio uses a precision medicine strategy to target, modify or deplete key cellular disease drivers.HI-Bio was established in 2021 in San Francisco, California.